Reported Safety Practices of Publicly Advertised Psychedelic Retreats

Area of Science:

• Psycho-pharmacology and mental health treatment modalities.
• Qualitative research methodologies in healthcare settings.

Background:

• The increasing availability of psychedelic retreats necessitates an understanding of their operational safety protocols.
• Despite historical Indigenous use, psychedelics carry inherent risks for certain individuals.

Purpose of the Study:

• To investigate the current safety precautions implemented by organizations offering psychedelic retreats.
• To identify variability in practices related to substance administration, health screening, and professional oversight.

Main Methods:

• A qualitative study involving structured interviews with representatives from 49 psychedelic retreat organizations.
• Data collection via phone or email from July to October 2023, with analysis from March 2024 to November 2025.
• Focus on organizational practices including substances offered, health screenings, medication protocols, and professional involvement.

Main Results:

• All surveyed organizations offered ayahuasca, psilocybin, or both; 38.7% offered multiple substances.
• While most collected medical histories and excluded individuals with certain conditions, practices varied significantly.
• Most organizations recommended medication washout (87.8%) and collaborated with (69.4%) or had (65.3%) health professionals present, but protocols lacked standardization.

Conclusions:

• Significant variability exists in safety precautions among psychedelic retreat organizations.
• Certain practices, particularly concerning medication washout and polysubstance use, may present elevated risks.
• There is a critical need for developing best practice guidelines, co-developed with diverse communities, including Indigenous and nonclinical groups.